Sedat Yildirim
Overview
Explore the profile of Sedat Yildirim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
589
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Akdag G, Isik D, Dogan A, Yildirim S, Kinikoglu O, Topal A, et al.
Medicina (Kaunas)
. 2024 Aug;
60(8).
PMID: 39202652
: Colorectal cancer (CRC) poses a major global health challenge, with high incidence rates and ongoing treatment debates. Adjuvant chemotherapy benefits for high-risk subgroups, particularly stage II disease, remain controversial....
12.
Akdag G, Dogan A, Yildirim S, Kinikoglu O, Mokresh M, Alomari O, et al.
Cureus
. 2024 Jul;
16(6):e63362.
PMID: 39070363
Background And Objective: Breast cancer (BC) remains a significant health concern, particularly in advanced stages where the prognosis is poor. The combination of endocrine therapy (ET) with cyclin-dependent kinase 4/6...
13.
Isik D, Kinikoglu O, Akdag G, Altintas Y, Turkoglu E, Yildirim S, et al.
Medicina (Kaunas)
. 2024 Jul;
60(7).
PMID: 39064516
: The treatment and escape for metastatic renal cell carcinoma (RCC) has rapidly evolved, particularly with the integration of immune therapies into first-line regimens. However, optimal strategies following progression in...
14.
Yildirim S, Dogan A, Akdag G, Cavdar E, Kinikoglu O, Oksuz S, et al.
Cancers (Basel)
. 2024 Jul;
16(14).
PMID: 39061152
Objective: Immunotherapies are commonly employed for the treatment of non-small-cell lung cancer (NSCLC). However, predictive biomarkers still need to be improved to predict responses to these agents. The lymphocyte-albumin (LA)...
15.
Cekmen N, Haka D, Torgay A, Karakaya E, Yildirim S, Haberal M
Exp Clin Transplant
. 2024 Jul;
22(5):402-405.
PMID: 38970286
Glycogen storage disease type 1 is a congenital abnormality of metabolism caused by the deficiency of the glucose-6-phosphatase enzyme, essential in glucose homeostasis. Patients with this disease are at high...
16.
Kinikoglu O, Odabas H, Altintas Y, Yildiz A, Cakan B, Akdag G, et al.
Medicina (Kaunas)
. 2024 Jun;
60(6).
PMID: 38929568
Patients with human epidermal growth factor receptor 2 (HER2) -positive, hormone receptor-positive (HR-positive) metastatic breast cancer (MBC) usually undergo trastuzumab emtansine (T-DM1) therapy in subsequent lines. Combining endocrine therapy (ET)...
17.
Yildirim S, Dogan A, Akdag G, Yuksel Yasar Z, Bal H, Kinikoglu O, et al.
Sci Rep
. 2024 May;
14(1):12123.
PMID: 38802494
Neoadjuvant chemotherapy (NACT) is the standard treatment for locally advanced, high-risk breast cancer. Pathological complete response (pCR) improves survival. Peripheral blood-derived indices reflecting systemic inflammation and nutritional status have long...
18.
Majidova N, Sari M, Kahvecioglu F, Ozcan E, Akdag M, Dogan A, et al.
Oncol Res Treat
. 2024 Apr;
47(7-8):360-367.
PMID: 38565096
Introduction: Nasopharyngeal carcinoma (NPC) accounts for 0.01% of all carcinomas, and 70% of patients have locally advanced disease with a poor prognosis. The mainstay therapy is chemoradiotherapy (CRT), and concurrent...
19.
Cekmen N, Uslu A, Torgay A, Araz C, Karakaya E, Yildirim S, et al.
Exp Clin Transplant
. 2024 Mar;
22(2):160-164.
PMID: 38511987
Alagille syndrome is an autosomal-dominantinherited disease characterized by intrahepatic bile duct involvement, congenital heart disease, eye anomalies, skeletal and central nervous system involvement, kidney anomalies, and facial appearance. Liver transplant...
20.
Kahraman S, Karakaya S, Kaplan M, Sezgin Goksu S, Ozturk A, Isleyen Z, et al.
Sci Rep
. 2024 Mar;
14(1):5820.
PMID: 38461209
Central nervous system (CNS) metastases can be seen at a rate of 30% in advanced stages for patients with non-small cell lung cancer (NSCLC). Growing evidence indicates the predictive roles...